@Gtrade. Pelase check carefully. The profitability of the company started to be deteriated started on 2019 QRs. Please consider that the Covid-19 pandemic and the reallocation of its factory in Jiangzhu, PRC has coused this weakneses.

Look the company profitability before 2019.....

Also, you can check their cash position and balance sheet strenghts.

-------------------------

Date Financial Year Quarter Revenue PBT

28 Sep 21 31 Mar 22 Q1 Jun 21 4,141 -8,066
30 Jun 21 31 Mar 21 - Mar 21 1,098 -16,365
31 Mar 21 31 Mar 21 - Dec 20 4,470 -21,755
30 Nov 20 31 Dec 20 Q3 Sep 20 4,845 -4,902
19 Aug 20 31 Dec 20 Q2 Jun 20 12,219 -50
30 Jun 20 31 Dec 20 Q1 Mar 20 11,257 -4,373
12 Mar 20 31 Dec 19 Q4 Dec 19 15,692 5,198
21 Nov 19 31 Dec 19 Q3 Sep 19 9,606 -666
27 Aug 19 31 Dec 19 Q2 Jun 19 21,710 3,131
31 May 19 31 Dec 19 Q1 Mar 19 18,040 1,399
27 Feb 19 31 Dec 18 Q4 Dec 18 15,704 -4,750
26 Nov 18 31 Dec 18 Q3 Sep 18 11,916 699
27 Aug 18 31 Dec 18 Q2 Jun 18 18,888 1,843
28 May 18 31 Dec 18 Q1 Mar 18 12,645 382
28 Feb 18 31 Dec 17 Q4 Dec 17 18,958 1,941
24 Nov 17 31 Dec 17 Q3 Sep 17 23,848 3,118
28 Aug 17 31 Dec 17 Q2 Jun 17 19,144 1,807
26 May 17 31 Dec 17 Q1 Mar 17 14,803 1,072
28 Feb 17 31 Dec 16 Q4 Dec 16 23,036 1,744
30 Nov 16 31 Dec 16 Q3 Sep 16 13,886 2,235
25 Aug 16 31 Dec 16 Q2 Jun 16 18,560 912
30 May 16 31 Dec 16 Q1 Mar 16 13,308 1,147
29 Feb 16 31 Dec 15 Q4 Dec 15 21,598 9,082
20 Nov 15 31 Dec 15 Q3 Sep 15 14,855 1,058
25 Aug 15 31 Dec 15 Q2 Jun 15 18,961 383
28 May 15 31 Dec 15 Q1 Mar 15 10,902 565
26 Feb 15 31 Dec 14 Q4 Dec 14 19,676 1,816
18 Nov 14 31 Dec 14 Q3 Sep 14 21,170 1,944
20 Aug 14 31 Dec 14 Q2 Jun 14 13,163 2,616
27 May 14 31 Dec 14 Q1 Mar 14 12,713 1,729
20 Feb 14 31 Dec 13 Q4 Dec 13 16,742 1,068
19 Dec 13 31 Dec 13 Q3 Sep 13 11,609 2,281

@Gtrade.

Please be selective in making assumption on different counters. Every counter has its streghts and weakneses.

Please study the fundamental and prospects of certain company before you make a conclusion.
Please study on Kanger fundamental,risks and prospects carefully........ TAYOR

wistlebower99. What is your comment on MyEg's proposed PP?

The NOSH of the company already 7.38 billion units.

What is the PURPOSE for MyEg to do PP?
To raise fund for new project, is it?
Its total issued share also will be increased.

Please give your valuable comment on this.
But I expect that you won't answer any questions.

BECAUSE YOU'RE ONLY THE SPAMMER GHOST IN EVERY COUNTER YOU SPAMMED.

@Gtrade. Are you part of the said syndicate???

It seems that you know all what is going to happen next.

Good then, THANK YOU for your GHOST STORIES!!!

MEMANG NAMPAK SIRIP IKAN YU YANG MAHU MENGAMBIL KESEMPATAN ATAS KETAKUTAN IKAN BILIS.

DALAM PELABURAN SAHAM NI, MACAM-MACAM ORANG ADE... TAYOR

Kuat-kuat spammer goncang pokok Kanger semalam. Mana dia orang hari ini? He He

Soon the company will announce all the scheduled dates for the RI exercises.

@Peace99.

559,339,038 units of shares acquired by Mr Sii Tung Nai was part of payment for acquiring Sung Master by Kanger.

The consideration for acqusition was by cash and issuance of the shares in Kanger to Sung Master.

The share price was considered @6 sen per share. No free warrant was detached with the shares acquired by Sung Master..

On behalf of the Board, UOBKH wishes to announce that the Board had on 28 October 2021 ("Price-Fixing Date") resolved to fix the issue price of the Rights Shares at RM0.12 per Rights Share ("Issue Price") and the exercise price of the Warrants at RM0.15 per Warrant ("Exercise Price")

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3204783

Gtrade please monitor the 32% fella. next 3 months
-----------------------
If they dispose their shares, there will be an announcement on it at BURSA. We can see it clearly if there is any announcement on it.

Kuat-kuat spammer goncang pokok Kanger hari ini.

Mereka masih minat nak beli kaunter tapi hendak beli pada harga murah.

@mansaham1972. Target awak 1.5 sen ya??? Mungkin ya, mungkin tidak!!!!

Kita tunggu saja. Mana tau ketiga-tiga pemegang saham substantial nak lelong saham mereka di pasaran!!!!

Saya cukup nak tengok, bagaimana cerdiknya Miss Chai dan Mr Sii Tung Nai membuat pelaburan saham. He He.

The emergence of three substantial shareholders of Kanger:

1. Sii Tung Nai (The party from Sung Master) 559,339,038 unit of shares (9.355 % shareholding)

2. Kuah Choon Ching - BOD of Kanger 819,513,179 unit of shares (13.707 % shareholding)

3. Miss Chai Woon Yun - The Daughter of Tan Sri Chai Kin Kong 416,700,000 unit of shares (9.26 % shareholding)

@GTrade.

I JUST WANT TO TAKE SOME POSITIVE NOTES ON THIS BIG PERCENTAGE OF SHAREHOLDING BY SUBSTANTIAL SHARE HOLDERS IN KANGER.

1. All those three substantial shareholders already took up 1,795,552,215 units of shares or 32.32 % of shareholding in Kanger.

2. Even the NOSH has been lifted up to 5,978,812,213, the share spread among retail investors was not getting widen.

3. The big shareholding among a few substantial investors give me more confidence on the company management and prospect.

4. Consider Sii Tung Nai (from Sung Master) as a substantial holder in Kanger. His reputation on managing Sung Master, an unlisted company with good results (as reported). Hope Kanger can get some good direction in managing the company for a better businesses.

wistlebower99. What is your comment on MyEg's proposed PP?

The NOSH of the company already 7.38 billion units.

What is the probability for MyEg to do the consolidation?
Is it high or low ? He He

And:

1. SAPNRG ( 5218 ) NOSH: 15.979 billion
2. Hong Seng ( 0041 ) NOSH 2.457 billion

Are these companies will do consolidation?

To remind all NEWBIES here, wistlebower99 is a total CONSOLIDATION GURU, a spammer who always use the CONSOLIDATION GHOST in any company he spammed.

https://klse.i3investor.com/servlets/cube/post/whistlebower99.jsp

But, from my simple observations, I like to conclude that Kanger WAS and STILL IN THE OPERATOR'S PLAY.


1. What are their objectives ?
I am not sure about it.

(a) Whether they are in the accumulation mode and will push the price after this?
or,

(b) Whether they are the operator/s who had accumulated a big amount of shares before the RI,
subscribing the RI or after the RI, and now just want to dispose their shares?

They maybe have TWO options:

- abandon the counter.

- accumulate shares @4.5 sen - 5.0 sen and later will push up the price.
This option is more possible based on the volume and the trend of buying @ 5 sen.

2. For whom/parties they are playing for ?

Still a mystery.

But, no announcement has been done rferring to disposal of shares from substantial share holders.

Therefore I concluded that:

1. The operator/s are not playing for the three substantial shareholders.

2. The operator/s maybe playing for the big shareholders (but not a substantial holders) or several
small operators / sharks are in play in this counter.

JUST MY 2 SEN ANALYSIS ONLY. TAYOR

Every counter has winners and victims. It's not depend to their share quantity.

Peace99 Is MDA approval easier to get?
-------------
I think so. Because its not influenced by the national vaccine policy. Just my opinion.

@Patience99. Need MDA aproval, not NPRA approval. The approval from MDA not yet emerged in MDA website.

@Peace99. ---- then can calculate average price as follows: RM 464mil/6billions=7.7sen/share.
Yes. Agree. He He

@Peace99.

1. Issued share capital = The sum of capital in RM collected from all the shares issued. The shares issued for Kanger is at different prices, such as @6 sen pershare for the RI shares, the PP shares with different prices,the IPO shares with certain price and ESOS shares with different price.

We can't calculate its average price, but the company can record the ammount in their accounting books.

Different term of capital:

2. Market capital = Total shares listed (or NOSH) x Listed share price

For illustrative purposes only,

----- the indicative issue price of RM0.12 per Rights Share
represents a discount of 34.78% to the TERP of Techfast Shares of RM0.18, calculated
based on the 5-day VWAP of Techfast Shares up to and including the 21 May 2021 being the latest practicable date to this announcement ("LPD") of RM0.313.

When the company will announce the ISSUE PRICE OF THE RI ????

Some possibilities:

Let say:
1. If the TERP is @ 20 sen, minimum issue price is @12 sen.
2. If the TERP is @ 23 sen, minimum issue price is @ 14 sen.
3. If the TERP is @ 26 sen. minimum issue price is @ 16 sen.

Currently, I'm keep monitoring the price movement until the company announcing it's ISSUE PRICE FOR THE RI.

The RI exercise will be the main factor that can influence the price of this stock.

I think the company will set the issue price for the RI around 12 sen - 20 sen only.

The lower price for the RI shares, theoritically will give more good results on their RI subscription rate.

Just my guessing..... TAYOR

Types of corporate proposal Exercise of Warrants
Details of corporate proposal Exercise of Warrants
No. of shares issued under this corporate proposal 500,000
Issue price per share ($$) Malaysian Ringgit (MYR) 0.0500

Date Announced 27 Oct 2021

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3203922
-----------

It's looking good for the mother share price. Give a good indication on its future prospects.

@Peace99. I can't elaborate or give my concrete analysis on why the transaction was at 5 sen. I don't have the info on that.

But, from my simple observations, I like to conclude that Kanger WAS and STILL IN THE OPERATOR'S PLAY.


1. What are their objectives ?
I am not sure about it.

(a) Whether they are in the accumulation mode and will push the price after this?
or,

(b) Whether they are the operator/s who had accumulated a big amount of shares before the RI,
subscribing the RI or after the RI, and now just want to dispose their shares?

They maybe have TWO options:

- abandon the counter.

- accumulate shares @4.5 sen - 5.0 sen and later will push up the price.
This option is more possible based on the volume and the trend of buying @ 5 sen.

2. For whom/parties they are playing for ?

Still a mystery.

But, no announcement has been done rferring to disposal of shares from substantial share holders.

Therefore I concluded that:

1. The operator/s are not playing for the three substantial shareholders.

2. The operator/s maybe playing for the big shareholders (but not a substantial holders) or several
small operators / sharks are in play in this counter.

JUST MY 2 SEN ANALYSIS ONLY. TAYOR

@pineapple123. The report of the investment on quoted shares, including BSL shares.

Its showed that as at 25 Oct 2021, the investment in quoted shares are profitable to the company.
.................

OTHERS BCM ALLIANCE BERHAD ("BCM") DEALINGS IN QUOTED SECURITIES UNDER RULE 9.20 OF THE ACE MARKET LISTING REQUIREMENTS

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3203769

Basis and justification of determining the issue price and Rights Shares

The issue price of the Rights Shares will be determined and fixed by the Board at a later date after receipt of all relevant approvals and after taking into consideration, amongst others, the following:-

i. the prevailing market conditions and market prices of Techfast Shares;

ii. the theoretical ex-rights price of Techfast Shares ("TERP") based on the 5-day
VWAP of Techfast Shares immediately preceding the price-fixing date; and

iii. Accordingly, the Board will fix the issue price of the Rights Shares at no less than RM0.12 each in order to achieve the said minimum amount to be raised from the Proposed Rights Issue with Warrants after taking into consideration the prevailing market conditions and market prices of Techfast Shares at the price-fixing stage, subject to a maximum allowable discount of not more than 50% to the TERP of Techfast Shares based on the 5-day VWAP of Techfast Shares immediately preceding the price-fixing date.

ESOS Options : A total of up to 104,908,225 option(s) to subscribe for Techfast Shares to
be granted to the Eligible Person(s) pursuant to the ESOS.

As at the LPD:-
(i) 46,816,480 options had been exercised at the exercise price of RM0.3204 each on 22 April 2021;

(ii) 8,573,388 options had been exercised at the exercise price of RM0.2916 each on 10 June 2021; and

(iii) 49,518,357 options that may be granted and exercised

Anyway, let us look at the three questions for us to get the answers:

Before the RI, the operators pushed down the price to the bottom.
Three big questions need the answers:

1. Now, are they trying to push up the price or pushed down the price?
Currently, the answer is they are pushing down the price.

Therefore:
To what price they intend to push down the price?

2. Are they planning to opt out from this counter later?

3. What will the three substantial share holders do about the Kanger share price?

@zzzzzzz. Ya lah. Nanti keluar hantu pocong. He He

wistlebower99. ... This is your advice.....

---- Better take a break for few months wait to see any improvement to quarterly financial results.
--+++++++++++

But you keep pissing your venom in this counter!!!!
What an ill intention spammer you are.... He He

Wistlebower99.

ANYWAY, KANGER WAS MORE DIVERSIFIED.

In near future, we should concern more on these potentials of the company:


1. The proceed from the disposal of assets (if done) will give positive short term impact on profitability of Kanger.

2. Expecting the expansion in Jingzhou will allow the Group to focus not only on manufacturing of bamboo products but also processing of bamboo related foodstuff and bamboo eco-tourism in the near future. The businesses should be improved when the Covid-19 pandemic settles in the near future.

3. The contribution from Sung Master also expected to help Kanger in terms of increasing the company's revenue and profitability in the near future.

Yes. It's my two sen prediction only.

@wistlebower99. Won't let you freely pissing your venom in this counter!!!!

We won't follow your ill-intention advice.. He He

@Gtrade. Orang tanya lain, awak jawab lain.... He He

The facts are:

1. It's not a MUST for the company to do consolidation, even when its NOSH is already huge.

2. Its should be OKAY for the company to do some types of share issuances, IF the objective of the issuance of shares is to collect fund for the betterment of the company, such as for financing the new good investments.

3. Even the good company such as MyEg needs to issue new shares in collecting new fund. Therefore, using the said method to collect fund for new investment in Kanger, I think also a JUSTIFIABLE exercise.

TAYOR

@jayden007. I think the company will set the issue price for the RI around 12 sen - 20 sen only. Just my guessing . TAYOR

MyEG plans private placement to raise as much as RM309mil

KUALA LUMPUR (Bernama) -- MyEG Services Bhd (MyEG) has proposed placement of up to 4.17% of its total number of issued shares to third party investors that would be identified later at an issue price to be determined later.

It said as of the latest practicable date, the total issued share of MyEG is valued at RM664.24 million comprising 7.38 billion shares, including 182 million treasury shares.

Source: https://www.klsescreener.com/v2/news/view/896503/myeg-plans-private-placement-to-raise-as-much-as-rm309mil

------------

GTrade and wistlebower99. What is your comment on MyEg's proposed PP?

The NOSH of the company already 7.38 billion units.

What is the probability for MyEg to do the consolidation?
Is it high or low ? He He

zzzzzzz. Hantu pocong sudah keluar ke?
Jaga-jaga. He He

Que buy some WB @0.5 sen.
In case there are some investors still want to dumb the warrant. 0.5 sen, it's very cheap, I think.
He He.

Yes. As I posted before.

Kanger has also been authorised by G42 to be the product registration holder and distributor of the Hayat-Vax vaccine in Malaysia.

On behalf of G42 Medications, Kanger said it had submitted applications to obtain the required approvals from the National Pharmaceutical Regulatory Agency for the Hayat-Vax vaccine to be used in Malaysia.

and:

Kanger will collaborate with ZP to facilitate the import, warehousing, and distribution of Covid-19 vaccines in Malaysia. "

Just for info.

For Duopharma case on COVILO Suspension for Injection COVID-19 Vaccine (Vero Cell), Inactivated

Holder : DUOPHARMA (M) SDN. BHD.
Importer : DUOPHARMA (M) SDN. BHD.
Manufacturer : Beijing Institute of Biological Products Co., Ltd. (BIBP)

Kanger has also been authorised by G42 to be the product registration holder and distributor of the Hayat-Vax vaccine in Malaysia.

-----------------
Which party could be named as the importer in Kanger's application with NPRA for Hayat-Vaxx vaccine ??

Its okay. Thank you.

Chill dear friend. There are to many people who want to throw spanner here. Why you're so mad???

@Noobie123. Will you give us the website address under NPRA website which has a list of importers, other than the said NPRA website address.

Will you please. It's good for confirmation on this issue.

@Noobie123. The list from NPRA shoud cover importers.

Please examine the site, where Kanger Medical International was listed.

............... quest-list-of-manufacturers-wholesalers-importers/quest-list-of-wholesalers.html

Full website address:

www.npra.gov.my/index.php/en/informationen/quest-list-of-manufacturers-wholesalers-importers/quest-list-of-wholesalers.html

@Noobie123. The license category listed for Kanger Medical International Sdn Bhd
is A. Category:A - Poison

--------------

Category: A, I think the highest level of license. Should cover vaccine. Please correct me if I am wrong.

------------------
Look at all the listed categories:

A- Poison; X-Non Poison; TM-Traditional; HS-Health Supplement; TMHS-Traditional & Health Supplement; Vet-Veterinary

@JK22. Thank you very much. It is true that Kanger Medical is on the NPRA list of Licensed Wholesalers in QUEST System !!!!

For members to check.

1. Please browse:

www.npra.gov.my/index.php/en/informationen/quest-list-of-manufacturers-wholesalers-importers/quest-list-of-wholesalers.html

2. “search” for Kanger Medical – and its should be there!!!

It’s a confirmation that Kanger is doing hard enough to secure the NPRA aproval for the Hayat-Vax vaccine.

@mansaham1972. Bagi saya positif saja. Kalau BOD senyap saja, dan hanya bergantung pada perniagaan BAMBOO di China, sedangkan perniagaan bamboo pada masa itu dalam proses perpindahan kilang dan penjualan (termasuk eksport) terjejas teruk akibat Covid-19 adakah awak fikir Kanger BERDAYA MAJU.

Saya sokong plan dan usaha Kanger untuk diversify perniagaan, terutama dalam perniagaan yang ada peluang daya maju.

Memang bukan semua plan perniagaan semestinya dapat dilaksanakan seperti dirancang. Namun, sebagai USAHAWAN, saya sokong BOD Kanger yang saya anggap bijak cuba mengambil peluang.

@Noobie123

Referring to the announcement by Kanger:

----- "The Board of Directors of Kanger wishes to announce that the Company is still waiting for the approval from National Pharmaceutical Regulatory Agency (NPRA)."
-------------

The announcement by the listed company should be binding by Law and Regulations.

I think, they could not simply say that ".... is still waiting for the approval..." if they do not applied for the approval yet. It will be misleading information given to the investors and public and the BOD will has a risk of breaching the law.... I think the BOD not dare to take the risks.

Therefore, I concluded that, Kanger has submitted the application for NPRA approval.

TRUE, the NPRA has their justifications to be fulfilled before approving the application.

Even the Sputnik V not yet approved by NPRA. INI MASALAH ROTI CANAI, NIE.. He He

@Noobie123. ... need to have Manufacturer’s Licence, Import Licence or Wholesale Licence.
------------

Just to share my notes on the proposed business.
BUT I'm NOT SURE about the TRUE SITUATION that happened in the company's plans and business. TAYOR



" Earlier this year, Sinopharm entered into a joint venture with UAE-based G42 to produce the Sinopharm Covid-19 vaccines in the country under the Hayat-Vax brand.

The made-in-UAE vaccine was the first Covid-19 vaccine to be produced in the Arab world.

"The Hayat-Vax vaccine is essentially the same Sinopharm Covid-19 vaccine, manufactured in the UAE. Hence, we are confident that it will be well-received and accepted by the Malaysian people as an effective vaccine towards the global fight against the Covid-19 pandemic," said Kuah.

Kanger has also been authorised by G42 to be the product registration holder and distributor of the Hayat-Vax vaccine in Malaysia.

On behalf of G42 Medications, Kanger said it had submitted applications to obtain the required approvals from the National Pharmaceutical Regulatory Agency for the Hayat-Vax vaccine to be used in Malaysia.

and:

Kanger will collaborate with ZP to facilitate the import, warehousing, and distribution of Covid-19 vaccines in Malaysia. "

Sinopharm (Beijing): BBIBP-CorV (Vero Cells) Vaccine Type: Inactivated.
This vaccine may also be referred to as Covilo. – This vaccine is approved by NPRA and registered by Duopharma as a registered holder.

This vaccine is also manufactured by G42 Healthcare (Hayat-Vax), the vaccine that Kanger is waiting for the approval from NPRA.

Source: https://covid19.trackvaccines.org/vaccines/5/